Short bowel syndrome often occurs in people whose small intestine has been surgically removed in half or more, leaving the remaining length of intestine no more than 120cm, associated with poor absorption of nutrients.

An important goal when treating patients with short bowel syndrome (short bowel syndrome) requiring parenteral nutrition or fluid support is to reduce dependence on this support and completely eliminate the use of these drugs. whenever possible.

Teduglutide, a recombinant, anti-aging, longer-acting GLP-2 analog, was shown in an open-label study to be safe, well tolerated, intestinal stimulant, and significantly increased absorption. Wet weight of the intestine, but no energy absorption in 16 short bowel syndrome patients with jejunostomy or colostomy.

Short bowel syndrome often occurs in people whose small intestine has been surgically removed in half or more, leaving the remaining length of intestine no more than 120cm, associated with poor absorption of nutrients. The small intestine is the organ that digests food and absorbs nutrients, resulting in people with short bowel syndrome not properly absorbing nutrients from food, vitamins, and water into the body to sustain life. .

Short bowel syndrome (SBS) is a malabsorption condition that is associated with a high frequency of complications and a high use of healthcare resources.

Successful treatment of patients with Short Bowel Syndrome (SBS) is dependent on residual intestinal adaptation, requiring a combination of pharmacological and nutritional therapy. Although the short bowel syndrome diet is quite similar for people with and without colonic segments, some key differences should be noted. This article focuses on dietary interventions that enhance adaptation, increase absorption and, as a result, reduce stool volume.

Short bowel syndrome is a malabsorption disorder whose common causes for extensive bowel resection are volvulus, Crohn's disease, mesenteric infarction, radiculitis, cancer, and congenital abnormalities. Medical treatment of short bowel syndrome is usually parenteral nutrition, oral feeding, and concomitant use of medications.

Short bowel syndrome is a malabsorptive condition associated with a high incidence of complications and high utilization of health care resources. Therefore, in some patients, physicians need to control food intake, in which controlling sugar, protein, and fat intake is extremely important.

Dietary therapy is an important component of care for patients with short bowel syndrome. The cornerstone of dietary therapy is the adjustment of food intake to maximize nutrient and fluid utilization by reducing stool output. Fecal output in short bowel syndrome is driven by fluid load exceeding the absorptive capacity of the shortened intestine; but other factors also contribute.